<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03341260</url>
  </required_header>
  <id_info>
    <org_study_id>CEBC-CU-2016-11-167</org_study_id>
    <nct_id>NCT03341260</nct_id>
  </id_info>
  <brief_title>Effect of Preoperative Diclofenac Potassium on Postoperative Endodontic Pain</brief_title>
  <official_title>Effect of Preoperative, Single-dose Diclofenac Potassium on Postoperative Endodontic Pain in Patients With Symptomatic Irreversible Pulpitis: A Double Blind Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the effect of preoperative a single-dose of 50 mg
      diclofenac potassium on postoperative endodontic pain in mandibular molars with symptomatic
      irreversible pulpitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with moderate-to-severe preoperative pain are selected. Patients receive either a
      single-dose of 50 mg diclofenac potassium (group A) or a placebo tablet as a control (group
      B). All patients receive the assigned premedication one hour before single-visit root canal
      treatment. Postoperative endodontic pain is measured at the following time points: 6 ,
      12,24,48 h after treatment. The incidence of analgesic intake is also recorded.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 2016</start_date>
  <completion_date type="Actual">April 2018</completion_date>
  <primary_completion_date type="Actual">February 2018</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The patients will be randomly divided into 2 groups:
Experimental group:
50 mg Diclofenac Potassium to be administered one hour before treatment.
Control group:
Placebo to be administered one hour before treatment.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative endodontic pain</measure>
    <time_frame>Up to 2 days after endodontic treatment</time_frame>
    <description>Pain after completion root canal treatment measured by Heft-parker visual analogue scale.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Analgesic intake</measure>
    <time_frame>Up to 2 days after endodontic treatment</time_frame>
    <description>The incidence of analgesic intake is recorded</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Pulpitis - Irreversible</condition>
  <arm_group>
    <arm_group_label>Diclofenac Potassium 50mg tab</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Diclofenac Potassium 50mg tablet to be administered one hour before treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo to be administered one hour before treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diclofenac Potassium 50mg Tab.</intervention_name>
    <description>A 50 mg tablet of the medication to be taken one hour before initiation of endodontic treatment.</description>
    <arm_group_label>Diclofenac Potassium 50mg tab</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>A placebo will be taken one hour before initiation of endodontic treatment.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with active pain (moderate-to-severe) in mandibular molars.

          -  Patients with prolonged response to cold testing and electric pulp tester.

          -  Patient with the ability to understand and use pain scales.

          -  Patient with vital coronal pulp tissue on access.

          -  Patient who accept to enroll to the study.

        Exclusion Criteria:

          -  Patients' allergies or any other contraindication to diclofenac potassium or
             articaine.

          -  Pregnant and lactating females.

          -  Patients having pain medication in the last 6 hours.

          -  Patient has more than one symptomatic mandibular tooth in the same quadrant.

          -  Patients with periradicular pathosis and/or radiolucency other than widened
             periodontal ligaments.

          -  Patients with active peptic ulcer and gastrointestinal disorders.

          -  Patients with history of bleeding problems or anticoagulant use within the last month.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amatallah H Al-Rawhani, Pos</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Oral and Dental Medicine/ Cairo University.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dentistry Faculty</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Elzaki WM, Abubakr NH, Ziada HM, Ibrahim YE. Double-blind Randomized Placebo-controlled Clinical Trial of Efficiency of Nonsteroidal Anti-inflammatory Drugs in the Control of Post-endodontic Pain. J Endod. 2016 Jun;42(6):835-42. doi: 10.1016/j.joen.2016.02.014. Epub 2016 Apr 12.</citation>
    <PMID>27080115</PMID>
  </reference>
  <reference>
    <citation>Metri M, Hegde S, Bhandi S. Effect of pretreatment diclofenac sodium on postendodontic pain: A randomised controlled trial. J Conserv Dent. 2016 Jan-Feb;19(1):7-10. doi: 10.4103/0972-0707.173183.</citation>
    <PMID>26957785</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 5, 2017</study_first_submitted>
  <study_first_submitted_qc>November 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 14, 2017</study_first_posted>
  <last_update_submitted>April 6, 2018</last_update_submitted>
  <last_update_submitted_qc>April 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Amatallah Hussein Nasser Al-Rawhani</investigator_full_name>
    <investigator_title>Postgraduate Student in Endodontic Department/ Faculty of Oral and Dental Medicine/ Cairo University.</investigator_title>
  </responsible_party>
  <keyword>Pulpitis, irreversible Pulpitis,</keyword>
  <keyword>Diclofenac Potassium</keyword>
  <keyword>Premedication, Preoperative Analgesic</keyword>
  <keyword>Postoperative pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulpitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diclofenac</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

